EIF2AK2 antibody (AA 2-18)
Quick Overview for EIF2AK2 antibody (AA 2-18) (ABIN2620306)
Target
See all EIF2AK2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2-18
-
Specificity
- Highly expressed in thymus, spleen and bone marrow compared to non-hematopoietic tissues such as small intestine, liver, or kidney tissues. Colocalizes with GSK3B and TAU in the Alzheimer disease (AD) brain. Elevated levels seen in breast and colon carcinomas,and which correlates with tumor progression and invasiveness or risk of progression. .
-
Cross-Reactivity (Details)
- No cross reactivity with other proteins.
-
Purification
- Immunogen affinity purified
-
Immunogen
- A synthetic peptide corresponding to a sequence at the N-terminus of human PKR(2-18aa AGDLSAGFFMEELNTYR).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Preservative
- Sodium azide, Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))
-
Alternative Name
- EIF2AK2 / PKR
-
Background
-
Name/Gene ID: EIF2AK2
Subfamily: Translational Control Kinase
Family: Protein Kinase
Synonyms: EIF2AK2, p1/eIF-2A protein kinase, p68 kinase, PRKR, EIF-2A protein kinase 2, p68, Protein kinase RNA-activated, Tik -
Gene ID
- 5610
-
Pathways
- DNA Damage Repair, ER-Nucleus Signaling, Hepatitis C
Target
-